Top-line Phase 2/3 data readout for COMPANION-002, evaluating tovecimig (CTX-009 - a DLL4 x VEGF-A bispecific antibody ... therapeutics to treat multiple human diseases, today reported full 2024 ...

Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.54. Tessa Romero – JPMorgan: Yigal ...

The full audited consolidated financial statements as of and for the year ended December 31, 2024, can be found in BioNTech's Annual Report on Form 20-F filed today with ... PD-L1 checkpoint ...

With its novel mechanism of action and durable therapeutic profile, UBX1325 could offer meaningful advantages over existing anti-VEGF treatments ... Fourth Quarter and Full Year Financial Results Cash ...

“In particular, when it comes to ocular conditions, doctors are so focused on the eye itself that they fail to take a full history ... required more anti-VEGF injections and had less improvement ...

Operator Good morning, and welcome to Ocugen's fourth quarter and full-year 2024 financial results and business update.

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

Today, I'll start by discussing our full year and fourth quarter performance ... in the DME patient journey in combination with anti-VEGF therapy. We expect preliminary top-line data from both ...

Our Form 10-K was also filed earlier this morning ... into one novel bispecific antibody that targets both PD-1 and VEGF. Next, I would like to review upcoming catalysts for this year and beyond.

Good morning, and welcome to Ocugen's fourth quarter and full-year 2024 financial results ... Finally, Ocugen's annual report on Form 10-K covering 2024 will be filed today. I will now turn ...

Westen Blot results showed that GSP can accelerate DU wound healing via AKT1/HIF-1α/VEGF axis. Conclusion ... which indicated that GSP could bind to AKT1 to form a stable complex. The docking of GSP ...

United States Agency for International Development (USAID) is a global leader in international development and humanitarian efforts, dedicated to saving lives, reducing poverty, strengthening ...